New stent shows promise for quicker heart vessel healing
NCT ID NCT06214819
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug-coated heart stent (VIVO ISAR) against a standard one (XIENCE Skypoint) in 40 people with coronary artery disease. Each patient receives both stents in different blocked arteries, and doctors use a special camera to check healing after one month. The goal is to see which stent allows the vessel lining to grow back faster, which may reduce risks like blood clots.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Clinic Barcelona
Barcelona, 08036, Spain
-
Hospital Universitari Vall D'Hebron
Barcelona, 08035, Spain
-
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, 08907, Spain
-
Hospital Universitario de Gerona Doctor Josep Trueta
Girona, 17007, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can common heart-surgery practices trigger delirium? a 5,600-patient hunt for clues.
- Can a phone app replace cardiac rehab? a new trial puts digital heart care to the test
- Step by step: a coaching program aims to keep heart patients moving after rehab
- Heart bypass upgrade: which Artery-Harvesting technique works best?
- Can a noble gas protect the heart during bypass surgery?
- A digital coach for the heart: app aims to keep risk factors in check after a heart attack